IL9 and cancer: Altogether, our data identified new pathway that is essential for the induction of IL-9 in Th9 and Th17, and thus could potentially be used in designing targeted therapies aimed at alleviating the course of IL-9-mediated allergic inflammation and cancer immunotherapy.